Metatron Inc (MRNJ): MRNJ>>>Page 13 of 6>>>...

MRNJ>>>Page 13 of 6>>>$400>>>$168,993>>>$(8,148,016)

yadotn · 2023-01-26T16:44:06.6670000Z

MRNJ>>>Page 13 of 6>>>$400>>>$168,993>>>$(8,148,016) MRNJ OTCMarkets PUBLISH DATE 11/15/2022 Metatron, Inc Page 13 of 6 Statements of Income For the Nine Months Ending September 30, 2022 (Unaudited) Revenues $400 Interest Expense $(41,326) Net (Loss) Income $(62,477) METATRON OTCMarkets PUBLISH DATE 11/15/2022 Page 12 of 6 Consolidated Balance Sheets As of September 30, 2022 (Unaudited) Accrued Interest 168,993 "During the nine months ended September 30, 2022, the Company had a net loss of $62,477 and an accumulated deficit of $8,148,016 as of September 30, 2022." https://www.otcmarkets.com/otcapi/company/financial-report/352001/content --- $400 $168,993 $(8,148,016)

Play Episode

3min

Proactive - Interviews for investors

Solvonis Therapeutics strengthens board with addition of Dr Renata Crome

Solvonis Therapeutics PLC (LSE:SVNS) non-executive director-elect Dr Renata Crome talked with Proactive about her appointment to the board and what she brings to the company. Dr Crome has an extensive background in pharmaceutical development, having worked at Roche for 30 years. She played a key role in the development of blockbuster treatments such as bevacizumab and obinutuzumab for cancer, as well as Tamiflu for influenza. Following her time at Roche, she transitioned to board roles across commercial and charity organisations and also lectures in pharmaceutical medicine. Discussing her contributions to Solvonis, Dr Crome highlighted her strategic expertise and experience in central nervous system (CNS) treatments. "I have extensive experience in developing treatments in the central nervous system area, and I know the challenges and some of the solutions," she said. She also emphasised her ability to leverage a strong network of experts to support the company's goals. Dr Crome expressed enthusiasm for Solvonis' innovative pipeline and differentiated treatments, as well as the strength of its leadership team. "It’s a privilege to be invited to join them," she said. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #SolvonisTherapeutics #Pharmaceuticals #Biotech #HealthcareInnovation #Leadership #CNSResearch #DrugDevelopment #Investing #Biopharma #ExecutiveLeadership

Proactive - Interviews for investors

Delivra Health expands Dream Water line with 6-count sleep gummies in Canada

Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to announce the launch of Dream Water 6-Count Sleep Gummies in the Canadian market. This new product builds on the success of the 60-count Dream Water Gummies, which debuted in Canada in February 2024 and received strong consumer demand. The 6-count version is set to hit distributors, retailers, and e-commerce channels in March 2025. Davey highlighted that this strategic launch is aimed at capturing growth opportunities in the travel and convenience retail sectors, reinforcing Delivra Health’s position as a leading provider of sleep solutions. By offering a smaller, on-the-go format, the company aims to expand its reach to travelers and impulse buyers, broadening accessibility for consumers seeking convenient sleep aids. The momentum behind Dream Water Sleep Gummies continues to build in both Canada and the U.S., with the new 6-count format being distributed nationwide through Delivra Health’s established retail and e-commerce partners. With this expansion, the company is set to further strengthen its footprint in the sleep wellness market. #proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #UAE #MiddleEastMarket #SleepAid #HealthAndWellness #PharmacyProducts #RegulatoryCompliance #DreamWater #SleepGummies #Wellness #SleepAid #TravelEssentials #CanadianRetail #HealthAndWellness #InsomniaRelief #SleepBetter

Proactive - Interviews for investors

Titan Minerals: new high-grade gold drill results

Titan Minerals Ltd CEO Melanie Leighton talked with Proactive about the latest drilling results at the Dynasty Gold Project in southern Ecuador. The company has reported strong extensional drill results, indicating significant growth potential, with mineralisation extending up to 150 metres below the current resource. One standout result includes 17.5 metres at 2.5 g/t gold and 8.6 g/t silver, with a high-grade section of 5 metres at 5.5 g/t gold and 10.7 g/t silver. Leighton highlighted that these results validate Titan’s strategy, confirming that the Dynasty gold system has substantial expansion potential. "Hole CVDD24-122 has been an incredibly successful hole for us," she said. "It has delivered multiple significant intersections from shallow depths while also highlighting the presence of wide, high-grade mineralisation at depth." Titan’s drilling campaign continues at Cerro Verde and other key targets, with assay results pending from several drill holes. Despite temporary weather-related delays, the company remains on track for a Mineral Resource estimate update in mid-2025. For more updates on Titan Minerals’ progress, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe to the channel, and turn on notifications for future updates. #TitanMinerals #ASX #ProactiveInvestors #GoldMining #DynastyGoldProject #MiningNews #Investing #GoldExploration #ResourceExpansion #DrillResults #EcuadorMining #MiningUpdates

Proactive - Interviews for investors

4GLOBAL CEO on new data intelligence platform & market growth

4GLOBAL PLC (AIM:4GBL) CEO Eloy Mazon talked with Proactive's Stephen Gunnion about the company’s continued expansion into North America and the launch of its new data intelligence platform, Insight.OS. Mazon explained that 4GLOBAL has built one of the world’s largest sports participation datasets, helping businesses gain insights into customer behaviour, operations, and investments. With Insight.OS, 4GLOBAL enhances data accessibility for clients. The platform offers three key benefits: improved data processing, flexibility in data visualisation across platforms, and AI-readiness. “It takes us into an AI-ready world where people will be able to access our data to power these new AI agents,” Mazon said. Additionally, Mazon discussed 4GSportsPulse, an expansion targeting sports brands and retailers. The platform helps businesses understand customer footfall and tailor their offerings. The North American market is a key focus for 4GLOBAL, and Mazon emphasized the company’s ongoing growth strategy. Looking ahead, 4GLOBAL will issue a trading update post-year-end on March 31st and remains focused on innovation, customer retention, and market expansion. For more insights from 4GLOBAL and other industry leaders, subscribe to Proactive’s YouTube channel, give this video a like, and turn on notifications for updates! #4GLOBAL #SportsData #AI #DataAnalytics #InsightOS #Investment #BusinessGrowth #NorthAmerica #SportsTech #AIInnovation

Followers	4
Posts	1343
Boards Moderated	0
Alias Born	12/28/2016

Volume:	2,018,000
Day Range:	0.000001 - 0.0001
Bid:	0.0001
Ask:	0.0001
Last Trade Time:	3:40:40 PM EDT
Total Trades:	4

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

MRNJ Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free